Contact Us

HDL Therapeutics, Inc.


We are a privately held cardiovascular device company and a leader in the field of reversing coronary atherosclerosis.

Our innovative acute care therapeutic device called PDS-2™ System transforms a patient’s own plasma into an atherosclerostic reversal agent using our patented technology.

Interested in a proven model for commercializing your science?